Oftentimes, a 5% dividend yield hints at a rather mature stage of business.
Finnair reports Q1 results on Apr 22. The unprecedented jet fuel price situation poses a big headach...
Ahead of Gofore’s Q1 report we continue to see signs of improving momentum.
The replacement cycle for electronics started in Q2/25 and we believe it will continue in 2026.
The Finnish grocery market remained stable in Q1, but we note the potential for material cost inflat...
* Q1e: Sales of SEK 1,143m (1,206m), EBIT of SEK 35m (13m) * US good but not great, Germany soft * T...
Redeye returns with an update following Guldbrev's strong Q1 report, which beat our estimates across...
Redeye views the proposed delisting, scheduled for 18 May, as the best course of action.
Redeye briefly comments on Isofol’s announcement that the German regulatory authority BfArM has appr...
* Strong Q1e: sales +196% y-o-y, 30% EBIT margin * Small estimate revisions * Ovzon-3 still not at f...
Redeye provides its initial take on VEF’s Q1 2026 report, which featured a slight NAV decline, drive...
InvesteraMera inleder uppdragsbevakning av Hansa Biopharma, ett bioteknikbolag vars läkemedel imlifi...
Redeye is impressed by Guldbrev’s Q1 report, which posted 86% top-line growth y/y, while EBITDA doub...
We leave our DCF-derived fair equity value range of SEK 120-164 unchanged ahead Duni’s Q1 report.
Under Q1 2026 förväntar Analysguiden en nettoomsättning på cirka 2 100 mkr, varav 1 300 mkr från Bei...
Revolution Medicines yesterday reported Phase 3 data for daraxonrasib, showing a near doubling of ov...
Revolution Medicines yesterday reported unprecedented phase III data for daraxonrasib in second-line...
Resekoncernen går in i 2026 med starkt momentum när både förvärvseffekter och intäktsförskjutningar ...
* We expect EBITA adj. of SEK 27m in Q1, -15% y-o-y * We cut '26e EBITA by 3% * We reiterate our fai...
Redeye comments on Carasent’s Q1 2026 report, which showed solid ARR growth marginally above our for...
Oil prices do not immediately drive Scanfil's sales volumes or EBIT margin.